References
- Argraves WS, Tanaka A, Smith EP, et al. (2009). Fibulin-1 and fibrinogen in human atherosclerotic lesions. Histochem Cell Biol 132:559–65
- Argraves WS, Tran H, Burgess WH, Dickerson K. (1990). Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure. J Cell Biol 111:3155–64
- Bagchi D, Bagchi M, Hassoun EA, Stohs SJ. (1995). In vitro and in vivo generation of reactive oxygen species, DNA damage and lactate dehydrogenase leakage by selected pesticides. Toxicology 104:129–40
- BeLue R, Okoror TA, Iwelunmor J, et al. (2009). An overview of cardiovascular risk factor burden in sub-Saharan African countries: a socio-cultural perspective. Global and Health 5:1–12
- Burke A, FitzGerald GA. (2003). Oxidative stress and smoking-induced vascular injury. Prog Cardiovasc Dis 46:79–90
- Cangemi C, Hansen ML, Argraves WS, Rasmussen LM. (2014). Fibulins and their role in cardiovascular biology and disease. Adv Clin Chem 67:245–62
- Cangemi C, Skov V, Poulsen MK, et al. (2011). Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes. Clin Chem 57:1556–65
- Dahl JS, Moller JE, Videbaek L, et al. (2012). Plasma fibulin-1 is linked to restrictive filling of the left ventricle and to mortality in patients with aortic valve stenosis. J Am Heart Assoc 1:e003889
- Devlin TM. (2002). Textbook of biochemistry with clinical correlations. New York: John Wiley & Sons Publication
- Dhalla NS, Temsah RM, Netticadan T. (2000). Role of oxidative stress in cardiovascular diseases. J Hypertens 18:655–73
- Godyna S, Diaz-Ricart M, Argraves WS. (1996). Fibulin-1 mediates platelet adhesion via a bridge of fibrinogen. Blood J 88:2569–77
- González-Flecha B, Curtin JC, Boveris A. (1993). Time course and mechanism of oxidative stress and tissue damage in rat liver subjected to in vivo ischemia-reperfusion. Am Soc Clin Invest 91:456–64
- Hamer M, Malan L, Schutte AE, et al. (2010). Conventional and behavioral risk factors explain differences in sub-clinical vascular disease between black and Caucasian South Africans: the SABPA study. Atherosclerosis 215:237–42
- Hinton RB, Lincoln J, Deutsch GH, et al. (2006). extracellular matrix remodeling and organization in developing and diseased aortic valves. J Am Heart Assoc 98:1431–8
- Jacob MP. (2003). Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed Pharmacother 57:195–202
- Jacob MP, Badier-Commander C, Fontaine V, et al. (2001). Extracellular matrix remodeling in the vascular wall. Pathol Biol 49:326–32
- Jomova K, Valko M. (2011). Advances in metal-induced oxidative stress and human disease. Toxicology 283:65–87
- Kato GJ, McGowan V, Machado RF, et al. (2006). Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood J 107:2279–85
- Kearney PM, Whelton M, Reynold K, et al. (2005). Global burden of hypertension: analysis of worldwide data. Lancet 365:217–23
- Kruger R, Rasmussen LM, Argraves WS, et al. (2014). Extracellular matrix biomarker, fibulin-1, is closely related to NT-proBNP and soluble urokinase plasminogen activator receptor in patients with aortic valve stenosis (The SEAS Study). PLoS One 9:e101522
- Kruger R, Schutte R, Huisman HW, et al. (2012). NT-proBNP is associated with fibulin-1 in Africans: the SAfrEIC study. Atherosclerosis 222:216–21
- Lee DH, Blomhoff R, Jacobs DR, Jr. (2004). Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 38:535–9.
- Lee HY, Oh BH. (2010). Aging and arterial stiffness. Circ J 74:2257–62
- Lee NV, Rodriguez-Manzaneque JC, Thai SN, et al. (2005). Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1. J Biol Chem 280:34796–804
- Lemarié CA, Tharaux PA, Lehoux S. (2010). Extracellular matrix alterations in hypertensive vascular remodeling. J Mol Cell Cardiol 48:433–9
- Norton K, Olds T. (2004). Anthropometrica. A textbook of body measurements for sports and health courses. Sydney: UNSW Press
- Samir Z. (2006). How is alcohol metabolized by the body? Alcohol Res Health 29:245–54
- Schacker TW, Nguyen PL, Beilman GJ, et al. (2002). Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis. J Clin Invest 110:1133–9
- Scholze A, Bladbjerg EM, Sidelmann JJ, et al. (2013). Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes. Cardiovas Diabetol 12:6–7
- Schutte AE, Schutte R, Huisman HW, et al. (2012). Are behavioural risk factors to be blamed for the conversion from optimal blood pressure to hypertensive status in Black South Africans? A 5-year prospective study. Int J Epidemiol 41:1114–23
- Valko M, Leibfritz D, Moncol J, et al. (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44–84
- Verhaar MC, Beutler JJ, Gaillard CA, et al. (1998). Progressive vascular damage in hypertension is associated with increased levels of circulating p-selectin. J Hypertens 16:45–50
- Wagenseil JE, Mecham RP. (2012). Elastin in large artery stiffness and hypertension. J Cardiovasc Translat Res 5:264–73
- Wallace S, McEniery CM, Dakham Z, et al. (2005). Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscl Thromb Vasc Biol 25:372–8
- Zatu MC, van Rooyen JM, Loots DT, et al. (2014). Self-reported alcohol intake is a better estimate of 5-year change in blood pressure than biochemical markers in low resource settings: the PURE study. J Hypertens 32:749–55